PAI1 (SERPINE1) Mouse Monoclonal Antibody [Clone ID: MA-33H1F7]
CAT#: AM26216PU-N
PAI1 (SERPINE1) mouse monoclonal antibody, clone MA-33H1F7, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 5820.00
Product images
Specifications
| Product Data | |
| Clone Name | MA-33H1F7 |
| Applications | ELISA, FN, WB |
| Recommend Dilution | Functional assay: Antibody MA-33H1F7 functions as an antagonist. The antibody was incubated with active PAI-1 and residual activity was measured by a functional assay (Ref.1). Western blot: A non-reduced sample treatment and SDS-Page was used. The band size is 52 kDa (Ref.5). The typical starting working dilution is 1:50. Immunassay. |
| Reactivity | Human, Mouse, Rat |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | This antibody detects PAI-1. The epitope of the antibody does not cover the complete alpha-helix F and turn connecting alpha-helix F and beta-strand s3A, but is restricted to the hinge region between alpha-helix F and the main part of the PAI-1 molecule. The monoclonal antibody MA-33H1F7 is a ‘switching’ antibody, capable of inducing a non-inhibitory substrate form of PAI-1. It was shown to inhibit PAI-1 in a dose dependent manner. |
| Isotype | IgG1 |
| Formulation | PBS State: Purified State: Liquid 0.2 µm filtered Ig fraction Stabilizer: 0.1% bovine serum albumin |
| Concentration | lot specific |
| Purification | Protein G |
| Conjugation | Unconjugated |
| Storage Condition | Store at 2 - 8 °C. |
| Gene Name | serpin family E member 1 |
| Database Link | |
| Background | Plasminogen activator inhibitor type-1 (PAI-1), a member of the serine protease inhibitor (serpin) superfamily, is an important protein in the regulation of fibrinolysis. PAI-1 is unique among the serpins because of its functional and conformational flexibility. PAI-1 is the most important physiological inhibitor of both tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA). Increased PAI-1 levels are associated with thrombotic events and is an established risk factor for cardiovascular diseases. The active conformation PAI-1 inhibits its target proteinases by the formation of a stable, inactive complex. Although PAI-1 is synthesized as an active molecule, it converts spontaneously to an inactive, latent form that can be partially reactivated by denaturing agents. In addition, a third conformation reacting as a non-inhibitory substrate towards various target proteinases has been identified. |
| Synonyms | Serpin E1, PLANH1, Plasminogen Activator Inhibitor 1, PAI-1, PAI |
| Reference Data | |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
其它SERPINE1产品
